These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9627304)

  • 1. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy.
    Sharpe-Timms KL; Keisler LW; McIntush EW; Keisler DH
    Fertil Steril; 1998 Jun; 69(6):1128-34. PubMed ID: 9627304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis.
    Mahutte NG; Matalliotakis IM; Goumenou AG; Koumantakis GE; Vassiliadis S; Arici A
    Fertil Steril; 2004 Jul; 82(1):97-101. PubMed ID: 15236996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis.
    Szamatowicz J; Laudański P; Tomaszewska I
    Hum Reprod; 2002 Feb; 17(2):284-8. PubMed ID: 11821264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions.
    Chegini N; Kotseos K; Bennett B; Diamond MP; Holmdahl L; Burns J;
    Fertil Steril; 2001 Dec; 76(6):1207-11. PubMed ID: 11730752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-13 and membrane type-1 matrix metalloproteinase in peritoneal fluid of women with endometriosis.
    Laudanski P; Szamatowicz J; Ramel P
    Gynecol Endocrinol; 2005 Aug; 21(2):106-10. PubMed ID: 16109597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory leukocyte protease inhibitor in ovarian endometriomas following GnRH agonist therapy.
    Suzumori N; Sato M; Ikuta K; Suzumori K
    Obstet Gynecol; 2001 Apr; 97(4):561-6. PubMed ID: 11275028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal fluid concentrations of interleukin-11 in women with endometriosis.
    Gazvani MR; Bates M; Vince G; Christmas S; Lewis-Jones DI; Kingsland C
    Fertil Steril; 2000 Dec; 74(6):1182-6. PubMed ID: 11119747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal vascular density assessment using narrow-band imaging and vascular analysis software, and cytokine analysis in women with and without endometriosis.
    Kuroda K; Kitade M; Kikuchi I; Kumakiri J; Matsuoka S; Kuroda M; Takeda S
    J Minim Invasive Gynecol; 2010; 17(1):21-5. PubMed ID: 19892605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.
    Huang HF; Hong LH; Tan Y; Sheng JZ
    Fertil Steril; 2004 May; 81(5):1235-9. PubMed ID: 15136083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis.
    Ryan IP; Tseng JF; Schriock ED; Khorram O; Landers DV; Taylor RN
    Fertil Steril; 1995 Apr; 63(4):929-32. PubMed ID: 7890085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentrations of cathepsin D in peritoneal fluid from women with endometriosis.
    Suzumori N; Ozaki Y; Ogasawara M; Suzumori K
    Mol Hum Reprod; 2001 May; 7(5):459-62. PubMed ID: 11331669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment.
    Wu MY; Chao KH; Chen SU; Chen HF; Yang YS; Huang SC; Ho HN
    Am J Reprod Immunol; 1996 Jun; 35(6):510-6. PubMed ID: 8792933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K; Bersinger NA; McKinnon B; Kostov P; Imboden S; Mueller MD
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):550-4. PubMed ID: 23993133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis.
    Imamura T; Khan KN; Fujishita A; Kitajima M; Hiraki K; Ishimaru T; Masuzaki H
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():16-23. PubMed ID: 25016551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis.
    Arici A; Matalliotakis I; Goumenou A; Koumantakis G; Vassiliadis S; Mahutte NG
    Fertil Steril; 2003 Oct; 80(4):889-94. PubMed ID: 14556808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation.
    Sharpe-Timms KL; Zimmer RL; Jolliff WJ; Wright JA; Nothnick WB; Curry TE
    Fertil Steril; 1998 May; 69(5):916-23. PubMed ID: 9591503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.
    Gilabert-Estellés J; Estellés A; Gilabert J; Castelló R; España F; Falcó C; Romeu A; Chirivella M; Zorio E; Aznar J
    Hum Reprod; 2003 Jul; 18(7):1516-22. PubMed ID: 12832381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility.
    Wang J; Zhou F; Dong M; Wu R; Qian Y
    Fertil Steril; 2006 Apr; 85(4):1037-44. PubMed ID: 16580392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis.
    Ho HN; Wu MY; Chao KH; Chen CD; Chen SU; Chen HF; Yang YS
    Am J Obstet Gynecol; 1996 Nov; 175(5):1236-41. PubMed ID: 8942494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis.
    Mahnke JL; Dawood MY; Huang JC
    Fertil Steril; 2000 Jan; 73(1):166-70. PubMed ID: 10632434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.